Gilead Sciences Inc beat Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by higher sales of HIV treatments, and the U.S. ...
Gilead results beat Street estimates as demand grows for HIV drug - Reuters
Read More
Bagikan Berita Ini
0 Response to "Gilead results beat Street estimates as demand grows for HIV drug - Reuters"
Post a Comment